Pamidronate: Treatment for Severe Hypercalcemia in Neonatal Subcutaneous Fat Necrosis

Publisher： Karger

E-ISSN： 1663-2826|65|6|289-294

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.65, Iss.6, 2006-06, pp. : 289-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commentary on ‘Pamidronate: Treatment for Severe Hypercalcemia in Neonatal Subcutaneous Fat Necrosis’ by Alos N. et al., Hormone Research 2006;65:289–294

By  

Hormone Research in Paediatrics, Vol. 70, Iss. 4, 2008-09 ,pp. : 254-255

Karger

Access to resources Recommend Favorite

Importance of the Renal Calcium Load as Putative Predictor for Nephrocalcinosis in Subcutaneous Fat Necrosis Associated with Severe Hypercalcemia

By  

Hormone Research in Paediatrics, Vol. 70, Iss. 4, 2008-09 ,pp. : 256-256

Karger

Access to resources Recommend Favorite

Treatment of Hypercalcaemia in Subcutaneous Fat Necrosis Is Controversial

By  

Hormone Research in Paediatrics, Vol. 68, Iss. 1, 2007-02 ,pp. : 31-31

Karger

Access to resources Recommend Favorite

Pamidronate Treatment of Children with Moderate-to-Severe Osteogenesis Imperfecta: A Note of Caution

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 1, 2008-11 ,pp. : 38-44

Karger

Access to resources Recommend Favorite

Intravenous Pamidronate Treatment in Children with Moderate-to-Severe Osteogenesis Imperfecta Started under Three Years of Age

By  

Hormone Research in Paediatrics, Vol. 79, Iss. 6, 2013-05 ,pp. : 333-340

Karger

Access to resources Recommend Favorite